Skip to main content
. 2023 Apr 8;128(12):2218–2226. doi: 10.1038/s41416-023-02258-2

Table 2.

Cox regression models for the associations between tumour necrosis percentage and survival in Cohorts 1 and 2.

Cancer-specific survival Overall survival
Tumour necrosis percentage No. of cases No. of events Univariable HR (95% CI) Multivariable HR (95% CI) No. of events Univariable HR (95% CI) Multivariable HR (95% CI)
Cohort 1
  <3% 100 15 1 (referent) 1 (referent) 42 1 (referent) 1 (referent)
  3–9.9% 577 145 1.73 (1.01–2.94) 1.76 (1.02–3.04) 278 1.19 (0.87–1.65) 1.19 (0.85–1.66)
  10–39.9% 327 107 2.45 (1.43–4.20) 2.35 (1.34–4.11) 173 1.41 (1.01–1.97) 1.44 (1.02–2.04)
  ≥40% 59 28 4.24 (2.27–7.94) 3.22 (1.68–6.17) 37 1.96 (1.26–3.05) 1.88 (1.19–2.97)
  Ptrend <0.0001 <0.0001 0.0010 0.0011
Cohort 2
  <3% 61 7 1 (referent) 1 (referent) 22 1 (referent) 1 (referent)
  3–9.9% 105 20 1.67 (0.71–3.94) 1.80 (0.71–4.60) 43 1.13 (0.68–1.89) 1.08 (0.62–1.88)
  10–39.9% 87 32 3.70 (1.63–8.39) 1.85 (0.75–4.55) 47 1.78 (1.07–2.94) 1.10 (0.62–1.96)
  ≥40% 31 17 7.53 (3.12–18.18) 3.39 (1.28–8.96) 21 3.14 (1.72–5.71) 1.70 (0.86–3.36)
  Ptrend <0.0001 0.018 <0.0001 0.19

HR hazard ratio, CI confidence interval.

Multivariable Cox regression models were adjusted for age (<65, 65–75, >75), sex (male, female), T (1–2, 3–4), N (0, 1–2), M (0, 1), tumour location (proximal colon, distal colon, rectum), year of operation (Cohort 1: 2000–2005, 2006–2010, 2011–2015; Cohort 2: 2006- Jan. 2010, Feb. 2010–2014), lymphatic or venous invasion (no, yes), grade (low-grade, high grade), MMR status (proficient, deficient), and BRAF status (wild-type, mutant). We excluded patients who died 30 days or less after having surgery (N = 37, in Cohort 1 and N = 3 in Cohort 2). Ptrend values were calculated by using the four ordinal categories of tumour necrosis percentage as a continuous variable in univariable and multivariable Cox proportional hazard regression models.